niacinamide has been researched along with ALS - Amyotrophic Lateral Sclerosis in 8 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study, we aim to verify whether swim training can improve lactate metabolism, NAD+ and NADH levels, as well as modify the activity of glycolytic and NADH shuttle enzymes and monocarboxylate transporters (MCTs) in skeletal muscle of amyotrophic lateral sclerosis (ALS) mice." | 8.12 | Swim Training Affects on Muscle Lactate Metabolism, Nicotinamide Adenine Dinucleotides Concentration, and the Activity of NADH Shuttle Enzymes in a Mouse Model of Amyotrophic Lateral Sclerosis. ( Antosiewicz, J; Cieminski, K; Dzik, KP; Flis, DJ; Kaczor, JJ; Wieckowski, MR; Ziolkowski, W, 2022) |
| "In this study, we aim to verify whether swim training can improve lactate metabolism, NAD+ and NADH levels, as well as modify the activity of glycolytic and NADH shuttle enzymes and monocarboxylate transporters (MCTs) in skeletal muscle of amyotrophic lateral sclerosis (ALS) mice." | 4.12 | Swim Training Affects on Muscle Lactate Metabolism, Nicotinamide Adenine Dinucleotides Concentration, and the Activity of NADH Shuttle Enzymes in a Mouse Model of Amyotrophic Lateral Sclerosis. ( Antosiewicz, J; Cieminski, K; Dzik, KP; Flis, DJ; Kaczor, JJ; Wieckowski, MR; Ziolkowski, W, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cieminski, K | 1 |
| Flis, DJ | 1 |
| Dzik, KP | 1 |
| Kaczor, JJ | 1 |
| Wieckowski, MR | 1 |
| Antosiewicz, J | 1 |
| Ziolkowski, W | 1 |
| Obrador, E | 2 |
| Salvador, R | 2 |
| Marchio, P | 2 |
| López-Blanch, R | 1 |
| Jihad-Jebbar, A | 1 |
| Rivera, P | 1 |
| Vallés, SL | 1 |
| Banacloche, S | 1 |
| Alcácer, J | 1 |
| Colomer, N | 1 |
| Coronado, JA | 1 |
| Alandes, S | 1 |
| Drehmer, E | 2 |
| Benlloch, M | 2 |
| Estrela, JM | 2 |
| Willyard, C | 1 |
| Blacher, E | 2 |
| Bedlack, R | 1 |
| de la Rubia, JE | 1 |
| Platero, JL | 1 |
| Caplliure-Llopis, J | 1 |
| Villaron-Casales, C | 1 |
| de Bernardo, N | 1 |
| AlarcÓn, J | 1 |
| Fuente, C | 1 |
| Carrera, S | 1 |
| Sancho, D | 1 |
| GarcÍa-Pardo, P | 1 |
| Pascual, R | 1 |
| JuÁrez, M | 1 |
| Cuerda-Ballester, M | 1 |
| Forner, A | 1 |
| Sancho-Castillo, S | 1 |
| Barrios, C | 1 |
| Holmes, HE | 1 |
| Dellinger, RW | 1 |
| Guarente, L | 1 |
| Bashiardes, S | 1 |
| Shapiro, H | 1 |
| Rothschild, D | 1 |
| Mor, U | 1 |
| Dori-Bachash, M | 1 |
| Kleimeyer, C | 1 |
| Moresi, C | 1 |
| Harnik, Y | 1 |
| Zur, M | 1 |
| Zabari, M | 1 |
| Brik, RB | 1 |
| Kviatcovsky, D | 1 |
| Zmora, N | 1 |
| Cohen, Y | 1 |
| Bar, N | 1 |
| Levi, I | 1 |
| Amar, N | 1 |
| Mehlman, T | 1 |
| Brandis, A | 1 |
| Biton, I | 1 |
| Kuperman, Y | 1 |
| Tsoory, M | 1 |
| Alfahel, L | 1 |
| Harmelin, A | 1 |
| Schwartz, M | 1 |
| Israelson, A | 1 |
| Arike, L | 1 |
| Johansson, MEV | 1 |
| Hansson, GC | 1 |
| Gotkine, M | 1 |
| Segal, E | 1 |
| Elinav, E | 1 |
| Wang, J | 1 |
| Zhang, Y | 1 |
| Tang, L | 1 |
| Zhang, N | 1 |
| Fan, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial[NCT04244630] | Phase 2 | 60 participants (Anticipated) | Interventional | 2022-04-01 | Recruiting | ||
| Impact of the Combined Treatment of Curcumin and Resveratrol Liposomed Polyphenols With G04CB02 on the Clinical Improvement of ALS Patients[NCT04654689] | Phase 2 | 90 participants (Actual) | Interventional | 2021-11-20 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for niacinamide and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study.
Topics: Aged; Amyotrophic Lateral Sclerosis; Disease Progression; Double-Blind Method; Drug Combinations; El | 2019 |
Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study.
Topics: Aged; Amyotrophic Lateral Sclerosis; Disease Progression; Double-Blind Method; Drug Combinations; El | 2019 |
Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study.
Topics: Aged; Amyotrophic Lateral Sclerosis; Disease Progression; Double-Blind Method; Drug Combinations; El | 2019 |
Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study.
Topics: Aged; Amyotrophic Lateral Sclerosis; Disease Progression; Double-Blind Method; Drug Combinations; El | 2019 |
7 other studies available for niacinamide and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Swim Training Affects on Muscle Lactate Metabolism, Nicotinamide Adenine Dinucleotides Concentration, and the Activity of NADH Shuttle Enzymes in a Mouse Model of Amyotrophic Lateral Sclerosis.
Topics: Adenine; Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Lactic Acid; Malate Dehydro | 2022 |
Nicotinamide Riboside and Pterostilbene Cooperatively Delay Motor Neuron Failure in ALS SOD1
Topics: Acetylcysteine; Amyotrophic Lateral Sclerosis; Animals; Antioxidants; Apoptosis; Cytokines; Female; | 2021 |
How gut microbes could drive brain disorders.
Topics: alpha-Synuclein; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Autism Spectrum Disorder | 2021 |
Can microbes combat neurodegeneration?
Topics: Akkermansia; Amyotrophic Lateral Sclerosis; Animals; Bacteria; Brain; Gastrointestinal Microbiome; H | 2021 |
ALSUntangled 42: Elysium health's "basis".
Topics: Adult; Amyotrophic Lateral Sclerosis; Humans; Male; Niacinamide; Pyridinium Compounds; Stilbenes | 2018 |
Potential roles of gut microbiome and metabolites in modulating ALS in mice.
Topics: Akkermansia; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Disease Models, Animal; | 2019 |
Protective effects of resveratrol through the up-regulation of SIRT1 expression in the mutant hSOD1-G93A-bearing motor neuron-like cell culture model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Annexin A5; Blotting, Western; Cell Death; Cell Survival; Cells, Cult | 2011 |